Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Sarepta Therapeutics
Sort By
Newest First
1 / 1
Gene Tools
Unlocking New Possibilities in Research, Therapeutics, and Beyond with Morpholino Antisense Oligos
David Alvaro, Ph.D.; Jon Moulton, Ph.D.
Pharma's Almanac
PAO-01-23-CL-05
Feb 01, 2023
Agreement
Hansa Biopharma Announces Exclusive Agreement with Sarepta Therapeutics to Develop Imlifidase as Pre-treatment Ahead of Gene Therapy
Sarepta Therapeutics, Inc
PR-M07-20-NI-004
Jul 03, 2020
Leadership
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
Sarepta Therapeutics, Inc
PR-M01-20-NI-033
Jan 21, 2020
CDMO
Yposkesi Selected to Produce Clinical and Large-Scale Commercial Material of Micro-Dystrophin for Genethon and Sarepta Therapeutics Program
Yposkesi
PR-M01-20-NI-015-1807
Jan 09, 2020
1 / 1
